![]() | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
| "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2020-04-24 Purchase | 2020-04-28 5:07 pm | Oric Pharmaceuticals Inc. | ORIC | GORDON CARL L Director 10% Owner | 281,250 | $16 | $4,500,000 | 281,250 (Indirect) | View |
2020-04-24 Purchase | 2020-04-28 5:13 pm | Oric Pharmaceuticals Inc. | ORIC | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director 10% Owner | 281,250 | $16 | $4,500,000 | 281,250 (Indirect) | View |
2020-11-04 Sale | 2020-11-05 08:56 am | Oric Pharmaceuticals Inc. | ORIC | Topspin Fund L.P. Topspin Biotech Fund II L.P. LG Management LLC GUTHART LEO 10% Owner | 2,268,750 | $0 | $0 | 1,100,446 (Indirect) | View |
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2020-04-23 Option Award | 2020-04-27 4:37 pm | N/A 2030-04-22 | Oric Pharmaceuticals Inc. | ORIC | Chacko Jacob CEO | 437,500 | $16 | 437,500 (Direct) | View |
2020-04-23 Option Award | 2020-04-27 4:38 pm | N/A 2030-04-22 | Oric Pharmaceuticals Inc. | ORIC | GORDON CARL L Director 10% Owner | 16,625 | $16 | 16,625 (Direct) | View |
2020-04-23 Option Award | 2020-04-27 4:39 pm | N/A 2030-04-22 | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 16,625 | $16 | 16,625 (Direct) | View |
2020-04-23 Option Award | 2020-04-27 4:40 pm | N/A 2030-04-22 | Oric Pharmaceuticals Inc. | ORIC | SCHELLER RICHARD H Director | 33,250 | $16 | 33,250 (Direct) | View |
2020-04-23 Option Award | 2020-04-27 4:41 pm | N/A 2030-04-22 | Oric Pharmaceuticals Inc. | ORIC | Svennilson Peter Director 10% Owner | 16,625 | $16 | 16,625 (Direct) | View |
2020-04-23 Option Award | 2020-04-27 4:41 pm | N/A 2030-04-22 | Oric Pharmaceuticals Inc. | ORIC | Dier Mardi Director | 33,250 | $16 | 33,250 (Direct) | View |
2020-04-23 Option Award | 2020-04-27 4:42 pm | N/A 2030-04-22 | Oric Pharmaceuticals Inc. | ORIC | Piscitelli Dominic CFO | 86,250 | $16 | 86,250 (Direct) | View |
2020-04-23 Option Award | 2020-04-27 4:43 pm | N/A 2030-04-22 | Oric Pharmaceuticals Inc. | ORIC | Multani Pratik S Chief Medical Officer | 147,500 | $16 | 147,500 (Direct) | View |
2020-04-28 Conversion | 2020-04-28 5:06 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Chacko Jacob CEO | 62,500 | $0 | 0 (Direct) | View |
2020-04-28 Conversion | 2020-04-28 5:06 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Chacko Jacob CEO | 62,500 | $0 | 0 (Direct) | View |
2020-04-24 Conversion | 2020-04-28 5:07 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | GORDON CARL L Director 10% Owner | 1,875,000 | $0 | 281,250 (Indirect) | View |
2020-04-24 Conversion | 2020-04-28 5:07 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | GORDON CARL L Director 10% Owner | 373,356 | $0 | 281,250 (Indirect) | View |
2020-04-24 Conversion | 2020-04-28 5:07 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | GORDON CARL L Director 10% Owner | 236,111 | $0 | 281,250 (Indirect) | View |
2020-04-24 Conversion | 2020-04-28 5:07 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | GORDON CARL L Director 10% Owner | 1,875,000 | $0 | 281,250 (Indirect) | View |
2020-04-24 Conversion | 2020-04-28 5:07 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | GORDON CARL L Director 10% Owner | 373,356 | $0 | 281,250 (Indirect) | View |
2020-04-24 Conversion | 2020-04-28 5:07 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | GORDON CARL L Director 10% Owner | 236,111 | $0 | 281,250 (Indirect) | View |
2020-04-28 Conversion | 2020-04-28 5:08 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 62,500 | $0 | 0 (Indirect) | View |
2020-04-28 Conversion | 2020-04-28 5:08 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Heyman Richard A. Director | 62,500 | $0 | 0 (Indirect) | View |
2020-04-28 Conversion | 2020-04-28 5:09 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | SCHELLER RICHARD H Director | 25,000 | $0 | 0 (Direct) | View |
2020-04-28 Conversion | 2020-04-28 5:09 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | SCHELLER RICHARD H Director | 25,000 | $0 | 0 (Direct) | View |
2020-04-28 Conversion | 2020-04-28 5:10 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Svennilson Peter Director 10% Owner | 3,500,000 | $0 | 0 (Indirect) | View |
2020-04-28 Conversion | 2020-04-28 5:10 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Svennilson Peter Director 10% Owner | 625,000 | $0 | 0 (Indirect) | View |
2020-04-28 Conversion | 2020-04-28 5:10 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Svennilson Peter Director 10% Owner | 416,666 | $0 | 0 (Indirect) | View |
2020-04-28 Conversion | 2020-04-28 5:10 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Svennilson Peter Director 10% Owner | 151,515 | $0 | 0 (Indirect) | View |
2020-04-28 Conversion | 2020-04-28 5:10 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Svennilson Peter Director 10% Owner | 3,500,000 | $0 | 0 (Indirect) | View |
2020-04-28 Conversion | 2020-04-28 5:10 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Svennilson Peter Director 10% Owner | 625,000 | $0 | 0 (Indirect) | View |
2020-04-28 Conversion | 2020-04-28 5:10 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Svennilson Peter Director 10% Owner | 416,666 | $0 | 0 (Indirect) | View |
2020-04-28 Conversion | 2020-04-28 5:10 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Svennilson Peter Director 10% Owner | 151,515 | $0 | 0 (Indirect) | View |
2020-04-28 Conversion | 2020-04-28 5:11 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Topspin Fund L.P. Topspin Biotech Fund II L.P. LG Management LLC GUTHART LEO 10% Owner | 231,250 | $0 | 0 (Direct) | View |
2020-04-28 Conversion | 2020-04-28 5:11 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Topspin Fund L.P. Topspin Biotech Fund II L.P. LG Management LLC GUTHART LEO 10% Owner | 497,809 | $0 | 0 (Direct) | View |
2020-04-28 Conversion | 2020-04-28 5:11 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Topspin Fund L.P. Topspin Biotech Fund II L.P. LG Management LLC GUTHART LEO 10% Owner | 314,815 | $0 | 0 (Direct) | View |
2020-04-28 Conversion | 2020-04-28 5:11 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Topspin Fund L.P. Topspin Biotech Fund II L.P. LG Management LLC GUTHART LEO 10% Owner | 2,268,750 | $0 | 0 (Indirect) | View |
2020-04-28 Conversion | 2020-04-28 5:11 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Topspin Fund L.P. Topspin Biotech Fund II L.P. LG Management LLC GUTHART LEO 10% Owner | 231,250 | $0 | 0 (Direct) | View |
2020-04-28 Conversion | 2020-04-28 5:11 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Topspin Fund L.P. Topspin Biotech Fund II L.P. LG Management LLC GUTHART LEO 10% Owner | 497,809 | $0 | 0 (Direct) | View |
2020-04-28 Conversion | 2020-04-28 5:11 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Topspin Fund L.P. Topspin Biotech Fund II L.P. LG Management LLC GUTHART LEO 10% Owner | 314,815 | $0 | 0 (Direct) | View |
2020-04-28 Conversion | 2020-04-28 5:11 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Topspin Fund L.P. Topspin Biotech Fund II L.P. LG Management LLC GUTHART LEO 10% Owner | 2,268,750 | $0 | 0 (Indirect) | View |
2020-04-24 Conversion | 2020-04-28 5:13 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director 10% Owner | 1,875,000 | $0 | 281,250 (Indirect) | View |
2020-04-24 Conversion | 2020-04-28 5:13 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director 10% Owner | 373,356 | $0 | 281,250 (Indirect) | View |
2020-04-24 Conversion | 2020-04-28 5:13 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director 10% Owner | 236,111 | $0 | 281,250 (Indirect) | View |
2020-04-24 Conversion | 2020-04-28 5:13 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director 10% Owner | 1,875,000 | $0 | 281,250 (Indirect) | View |
2020-04-24 Conversion | 2020-04-28 5:13 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director 10% Owner | 373,356 | $0 | 281,250 (Indirect) | View |
2020-04-24 Conversion | 2020-04-28 5:13 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director 10% Owner | 236,111 | $0 | 281,250 (Indirect) | View |
2020-04-28 Conversion | 2020-04-28 5:42 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | COLUMN GROUP II LP Column Group II GP LP GOEDDEL DAVID V 10% Owner | 3,500,000 | $0 | 0 (Direct) | View |
2020-04-28 Conversion | 2020-04-28 5:42 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | COLUMN GROUP II LP Column Group II GP LP GOEDDEL DAVID V 10% Owner | 625,000 | $0 | 0 (Direct) | View |
2020-04-28 Conversion | 2020-04-28 5:42 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | COLUMN GROUP II LP Column Group II GP LP GOEDDEL DAVID V 10% Owner | 416,666 | $0 | 0 (Direct) | View |
2020-04-28 Conversion | 2020-04-28 5:42 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | COLUMN GROUP II LP Column Group II GP LP GOEDDEL DAVID V 10% Owner | 151,515 | $0 | 0 (Direct) | View |
2020-04-28 Conversion | 2020-04-28 5:42 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | COLUMN GROUP II LP Column Group II GP LP GOEDDEL DAVID V 10% Owner | 3,500,000 | $0 | 0 (Direct) | View |
2020-04-28 Conversion | 2020-04-28 5:42 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | COLUMN GROUP II LP Column Group II GP LP GOEDDEL DAVID V 10% Owner | 625,000 | $0 | 0 (Direct) | View |
2020-04-28 Conversion | 2020-04-28 5:42 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | COLUMN GROUP II LP Column Group II GP LP GOEDDEL DAVID V 10% Owner | 416,666 | $0 | 0 (Direct) | View |
2020-04-28 Conversion | 2020-04-28 5:42 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | COLUMN GROUP II LP Column Group II GP LP GOEDDEL DAVID V 10% Owner | 151,515 | $0 | 0 (Direct) | View |
2020-06-09 Option Award | 2020-06-10 5:09 pm | N/A 2030-06-08 | Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director | 28,515 | $35.92 | 28,515 (Direct) | View |
2021-02-01 Option Award | 2021-02-02 7:29 pm | N/A 2031-01-31 | Oric Pharmaceuticals Inc. | ORIC | Chacko Jacob CEO | 280,000 | $29.83 | 280,000 (Direct) | View |
2021-02-01 Option Award | 2021-02-02 7:31 pm | N/A 2031-01-31 | Oric Pharmaceuticals Inc. | ORIC | Multani Pratik S Chief Medical Officer | 90,000 | $29.83 | 90,000 (Direct) | View |
2021-02-01 Option Award | 2021-02-02 7:32 pm | N/A 2031-01-31 | Oric Pharmaceuticals Inc. | ORIC | Piscitelli Dominic CFO | 90,000 | $29.83 | 90,000 (Direct) | View |